Increasing Prevalence Of Neurological Disorders Worldwide is Escalating Brain Monitoring Market Through 2027

Increasing prevalence of neurological disorders over many years, like Parkinson’s disease, Epilepsy, Alzheimer’s disease and others act as the major factors in driving the growth of the global brain monitoring market. This can primarily be attributed to the growing geriatric population.

Having a seizure can result in injury due to falling, drowning, or car accidents, but perhaps the most common cause of death from epilepsy is from sudden unexpected death in epilepsy (SUDEP). SUDEP is still poorly understood, but is assumed to be associated with respiratory, cardiac, and cerebral factors. In 2019, there were 1,852?deaths in the U.S.?with epilepsy as the underlying cause.?Rates of death from epilepsy?are higher for older people, with 1.6 deaths per 100,000 population among those aged 85 years and older, compared to an average rate of around 0.5 among those aged 15 to 24 years.

The launches of novel products related to brain monitoring are also expected to propel the market growth over the forecast period. In In March 2018, Nihon Kohden (Japan) launched aireeg WEE-1200, a wireless EEG system that provides real-time data during long-term epilepsy monitoring, intensive care, and routine EEG.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=8941

Also, In March 2019, Masimo (US) received CE Mark approval for its next-generation SedLine brain function monitor for pediatric patients aged between one and 18 years of age; this product assesses the brain function while the patient is under anesthesia.

According to UnivDatos Market Insights (UMI)’ research report “Global Brain monitoring Market Analysis, 2020”, the Brain monitoring market is projected to grow at a CAGR of XX% during 2021-27F. The demand for Brain monitoring market is increasing on account of increasing incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases, growth in the number of traumatic brain injuries, and increasing applications of brain monitoring in clinical trials.

Based on product, the market the global Brain Monitoring market is segmented into devices and accessories. Among them, devices segment held the largest share of the brain monitoring market in 2020. This is mainly due to the rising incidence of neurological, neurodegenerative, psychotic, and sleep disorders, the need for early diagnosis, the availability of innovative portable and wearable home-based monitoring devices, and increasing patient awareness. Devices are further sub-segmented into electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices and electromyography (EMG) devices. The electroencephalograph market is the dominating product segments in this market. High prevalence of epilepsy and sleep disorders coupled with the presence of high unmet medical needs in these segments attribute for its market share.

In terms of Procedure, Based on procedure, the market is categorized into invasive and non-invasive. Out of which, the non-invasive segment is projected to show fastest growth during the forecast period. This high growth can be ascribed to rise in incidences of traumatic brain injuries, high acceptance rate of minimally invasive devices, and low risk of mortality. This increases the demand for these products that propels the market growth.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=8941

Furthermore, drawbacks of invasive monitoring are driving the demand for devices for non-invasive procedures. On the other hand, higher accuracy of devices used for invasive procedures has ensured their adoption of invasive procedures.

North America to Grab Lion’s Share, Asia-Pacific to register the fastest growth

In terms of geography, this market is dominated by the North American region owing to increasing incidence and prevalence of neurological disorders, growing number of clinical trials of brain monitoring products and the availability of medical reimbursement in the US.

Approximately 30,000 people in America had Huntington’s disease, and more than 200,000 people were at risk in 2017 according to Huntington’s Disease Society of America. Additionally, the average incidence of epilepsy each year in the US is estimated at 150,000 or 48 for every 100,000 people (Source: Epilepsy Foundation). In the US, around 3.4 million people are affected by epilepsy.

The high adoption of technology and high penetration of mobile device have given this market an edge over other regions. The brain monitoring devices market in North America is also being encouraged by the supportive regulatory framework and affordable healthcare plans. ?

The United States market had the highest revenue in the North American region for Brain Monitoring market owing to favorable reimbursement policies, increasing technological advancements (including the development of mobile EEG machines, real-time monitoring, and alerts).

According to the US National Institute of Mental Health (NIMH), it has been estimated that one in four American adults suffer from a diagnosable mental disorder in any given year, and nearly 6% suffer?from serious disabilities. The same source has also stated that the total cost of serious mental illness in the United States exceeds USD 317 billion, per year.

Each year, around 235,000 patients are hospitalized in the United States with Traumatic Brain Injury with a significant portion having severe TBI. In the United States, about 30,000 people each year have an aneurysmal subarachnoid hemorrhage with a mortality close to 50%. However, Asia-Pacific is expected to skyrocket with a CAGR of XX% in the forecast period owing, as stated in UnivDatos Market Insights (UMI)’ research report “Global Brain monitoring Market Analysis, 2020”.?

For more informative information, please visit us – https://univdatos.com/report/brain-monitoring-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global brain monitoring market include Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Siemens Healthineers, Compumedics, Ltd., Medtronic, CAS Medical Systems, Dr?gerwerk AG & Co. KGaA and Masimo Corporation. Major companies are undertaking various strategic initiatives including mergers and acquisitions, collaborations, new product development and launch, and regional expansions for serving the unmet customer needs. Some of the instances are:

·???????In March 2019, Masimo (US) received CE Mark approval for its next-generation SedLine brain function monitor for pediatric patients aged between one and 18 years of age; this product assesses the brain function while the patient is under anesthesia.

·???????In March 2018, Nihon Kohden (Japan) launched aireeg WEE-1200, a wireless EEG system that provides real-time data during long-term epilepsy monitoring, intensive care, and routine EEG.

·???????In 2018, GE Healthcare launched its SIGNA Premier 3.0T magnetic resonance imaging (MRI) system in Canada.

·???????In 2018, Philips collaborated with Samsung Electronics to connect Samsung’s ARTIK Smart IoT Platform to Philips’ HealthSuite Digital Platform. This addressed the growing need for connected health platforms that can safely access, share, and analyze information, helping health systems and providers achieve their goal of delivering better care to consumers.

·???????In 2017, Natus acquired the global Camino ICP monitoring product line, including its San Diego manufacturing facility, from Integra. The sale also included the US rights to Integra's fixed-pressure shunts, as well as US rights to Codman's DURAFORM dural graft implants, standard EVD catheters, and CSF collection systems.

·???????In 2017, Philips acquired Electrical Geodesics to expand its existing portfolio of imaging technologies and advanced informatics for neurological applications.

“Global Brain monitoring Market Analysis , 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for manufacturers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.??????

For more informative information, please visit us – ?https://univdatos.com/report/brain-monitoring-market/

Market Segmentation:

1.?????By Product (Devices And Accessories)

2.?????By Disease (Traumatic Brain Injury (Tbi), Stroke, Dementia, Headache Disorders, Sleep Disorders, Parkinson’s Disease, Epilepsy, Huntington’s Disease, And Other Diseases)

3.?????By Procedure (Invasive And Non-Invasive)

4.?????By End-Users (Hospitals, Neurology Centers, Diagnostic Centers, Ascs & Clinics, And Other End Users)

5.?????By Region (North America, Europe, Asia-Pacific, Rest of the World)

6.?????By Company (Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Siemens Healthineers, Compumedics, Ltd., Medtronic, CAS Medical Systems, Dr?gerwerk AG & Co. KGaA and Masimo Corporation)

Key questions answered in the study:

1.?????What are the current and future trends of the Global Brain monitoring industry?

2.?????How the industry has been evolving in terms of end-user demand, application and product areas?

3.?????How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.?????What are the key growth drivers and challenges for the Brain monitoring industry?

5.?????What are the customer orientation, purchase behavior, and expectations from the Brain monitoring firms across various regions??